Hypotriglyceridemias/hypolipidemias

Clin Investig Arterioscler. 2021 May:33 Suppl 2:63-68. doi: 10.1016/j.arteri.2020.12.011.
[Article in English, Spanish]

Abstract

Hypolipoproteinemias are characterized by a decrease in the plasma concentration of lipoproteins. Within them, we find two groups: hypobetalipoproteinemias (HBL), due to a decrease in the plasma concentration of lipoproteins containing apolipoprotein B, and hypoalphalipoproteinemias. Hypolipoproteinemias can be classified according to their origin, into primary and secondary. Primary HBLs are rare entities produced by mutations in different genes. So far, more than 140 mutations have been identified in the APOB, PCSK9, ANGPTL3, MTTP, and SAR1 genes. Early diagnosis and treatment are essential to avoid the development of serious complications. In this review we address the diagnosis and treatment of HBL, especially those in which there is hypotriglyceridemia.

Keywords: Abetalipoproteinemia; Familial hypobetalipoproteinemia; Hipobetalipoproteinemia familiar; Hipolipidemia; Hipotrigliceridemia; Hypolipidemia; Hypotriglyceridemia.

Publication types

  • Review

MeSH terms

  • Angiopoietin-Like Protein 3
  • Angiopoietin-like Proteins
  • Apolipoproteins B / genetics
  • Humans
  • Hypobetalipoproteinemias
  • Hypolipoproteinemias*
  • Mutation
  • Proprotein Convertase 9

Substances

  • ANGPTL3 protein, human
  • Angiopoietin-Like Protein 3
  • Angiopoietin-like Proteins
  • Apolipoproteins B
  • PCSK9 protein, human
  • Proprotein Convertase 9